Published by
@ShahidNShah
@ShahidNShah
AI Assistance In Clinical Trials: The Practical Opportunities
Clinical trials are costly and slow, have low success rates but are essential in improving healthcare. Let's see the various ways AI can help the process.
With overall success rates under 8%, conducting clinical trials for drug development is a high-risk endeavour for pharmaceutical and biotechnology companies. However, the process is an essential part of providing and improving healthcare, as well as a crucial part of the pharmaceutical business. Considering the low success rates in this industry, improvements are evidently needed. Recent developments in the artificial intelligence (AI) field indicate that the technology could provide assistance in clinical trials.
We previously considered the long-term role of AI in clinical trials such as in developing artificial patients and predicting adverse events. In this article, we focus on the technology’s near-term, practical potential in assisting in improving the clinical trial process.
Read on medicalfuturist.com
Continue reading at medicalfuturist.com
Make faster decisions with community advice
- With Microsoft and Google, White House offers cybersecurity tools for rural hospitals
- Beyond the Basics: Expanding the Scope of Remote Patient Monitoring for Chronic Disease Management
- Data Security and Compliance: How Custom EHR Ensures Patient Information Protection
- Helix Launches Clinico-Genomic Datasets to Accelerate Precision Medicine Drug Discovery
- Patients are bullish on the benefits of genAI, but still have qualms
Next Article
-
With Microsoft and Google, White House offers cybersecurity tools for rural hospitals
The AHA and National Rural Health Association are also onboard for the initiative, which will offer grants, free endpoint security advice and other resources for critical access and emergency …
Posted Jun 12, 2024 Privacy & Security SecurityRisks Cybersecurity Hospital Care
